Vitacrystallography: Appearance and Development of Cancer-Induced Structural Biomarkers in a Mouse Model

As prostate cancer affects 1 in 9 men worldwide with 1.5 million new cases annually, developing innovative diagnostic approaches is more critical than ever. Our study introduces "Vitacrystallography" - using X-ray scattering to track cancer progression at the molecular level.

📊 Key Breakthrough Findings:
✅ Successfully tracked prostate cancer progression in mouse models over 16 days
✅ Identified universal structural biomarkers across species (mouse) and organs (prostate vs. previous breast studies)
✅ Demonstrated lipid peak reduction and water peak increase as cancer advances
✅ Established cancer trajectory framework for real-time treatment monitoring
✅ Validated biomarkers detectable with both synchrotron and laboratory X-ray equipment

🔬 What makes this special:
First application of X-ray scattering to prostate cancer progression
Cross-species validation enhances translational potential
Cancer trajectory mapping enables personalized treatment monitoring
Potential for in vivo measurements up to 10cm tissue thickness
This research represents a major step toward molecular-level cancer diagnostics that could revolutionize how we detect, monitor, and treat cancer across multiple organ systems.

Huge gratitude to my incredible co-authors and the teams at Ulster University, Keele University, and Diamond Light Source for making this research possible! 🙌

🔗 Read the full open-access paper: Vitacrystallography: Appearance and Development of Cancer-Induced Structural Biomarkers in a Mouse Model